Oral melphalan for the treatment of relapsed canine lymphoma

Publisher： John Wiley & Sons Inc

E-ISSN： 1476-5829|16|1|E123-E129

ISSN： 1476-5810

Source： VETERINARY AND COMPARATIVE ONCOLOGY, Vol.16, Iss.1, 2018-03, pp. : E123-E129

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mechlorethamine, vincristine, melphalan and prednisone (MOMP) for the treatment of relapsed lymphoma in dogs

By  

VETERINARY AND COMPARATIVE ONCOLOGY, Vol. 13, Iss. 4, 2015-12 ,pp. : 398-408

John Wiley & Sons Inc

Access to resources Recommend Favorite

Rabacfosadine for relapsed canine B‐cell lymphoma: Efficacy and adverse event profiles of 2 different doses

By  

VETERINARY AND COMPARATIVE ONCOLOGY, Vol. 16, Iss. 1, 2018-03 ,pp. : E76-E82

John Wiley & Sons Inc

Access to resources Recommend Favorite

A dexamethasone, melphalan, actinomycin‐D and cytarabine chemotherapy protocol as a rescue treatment for feline lymphoma

By  

VETERINARY AND COMPARATIVE ONCOLOGY, Vol. 16, Iss. 1, 2018-03 ,pp. : E144-E151

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pilot clinical study of carmustine associated with a lipid nanoemulsion in combination with vincristine and prednisone for the treatment of canine lymphoma

By  

VETERINARY AND COMPARATIVE ONCOLOGY, Vol. 13, Iss. 3, 2015-09 ,pp. : 184-193

John Wiley & Sons Inc

Access to resources Recommend Favorite

Oral glucocorticoid pulse therapy for induction of treatment of canine pemphigus foliaceus – a comparative study

By  

VETERINARY DERMATOLOGY, Vol. 26, Iss. 5, 2015-10 ,pp. : 354-e77

John Wiley & Sons Inc

Access to resources Recommend Favorite